unknown
Stage
About
Aitia develops a Gemini Digital Twin platform that uses causal AI and multiomic patient data to create in silico models of human disease biology, aiding pharmaceutical companies in drug discovery and development.
Explore Aitia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.